Complex regional pain syndrome

2 trials MedDRA PT
2 Registered trials
0 Recruiting
2 Unique sponsors
2 Unique IMPs
0 Commercial trials
Drug classes (ATC)
M Musculoskeletal (ATC M) 1
N Neurology/Psychiatry (ATC N) 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase II: 1 Phase IV: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase II

1 trial
  • Rigshospitalet Academic
    CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS
    2024-519832-17-00 1 country 2026 n=25
    Halted

Phase IV

1 trial
  • Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) Academic
    ESKETAMINE HYDROCHLORIDE
    2024-511877-31-00 1 country 2024 n=60
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Rigshospitalet Academic 1 Phase II 0
Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) Academic 1 Phase IV 0
New trials by year
2024
1
2026
1
← All indication landscapes